On that we agree, but chemo is an evil that many cancer patients can’t avoid. Until we have alternatives for every cancer patient we need to make chemo better and safer for those with no other choice.
- Forums
- ASX - By Stock
- RAC
- CPACS: Research, Results, Market Comparisons, and Valuations
CPACS: Research, Results, Market Comparisons, and Valuations, page-84
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.61 |
Change
0.000(0.00%) |
Mkt cap ! $273.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 21870 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.60 | 289 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 21870 | 1.605 |
2 | 1817 | 1.580 |
1 | 20000 | 1.560 |
1 | 6000 | 1.500 |
1 | 4205 | 1.450 |
Price($) | Vol. | No. |
---|---|---|
1.600 | 289 | 1 |
1.640 | 12136 | 1 |
1.650 | 17920 | 3 |
1.690 | 585 | 1 |
1.750 | 14309 | 3 |
Last trade - 09.45am 13/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online